HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Menière's disease and isosorbide as an oral hyperosmotic agent (author's transl)].

Abstract
According to a nationwide survey in 1977 and average of 54.7% of Menière's disease patients were unable to function normally in their daily lives. These patients mostly complained of repeated attacks of vertigo (male 40.3%, female 29.2%) (Watanabe et al. 1980). For the purpose of improving the repeated attacks of vertigo, Isosorbide as an oral hyperosmotic diuretic was first administered orally to 21 patients with Menière's disease from November 1979 to January 1981 for reducing the endolymphatic hydrops that can be presumed to be of pathogenetic importance. The electrocochleographic examinations were carried out on these patients at the same time. Usually, the SP/AP wave form in the electrocochleographic examinations appears to be more abnormal in patients with a fluctuating hearing loss or a flat hearing loss. The average of negative SP/AP in 24 patients with Meniére's disease was 0.54. The indication of Isosorbide administration was determined by this particular SP/AP wave abnormality, and clinical of Isosorbide for the patients with Menière's disease were evaluated. In 18 patients who experienced relief, attack of vertigo did not occur in 12 (63%) and vertigo was relieved in six (31%). In two patients with long administration, hearing improvement could already be observed during the period of treatment. The electrocochleographic examinations showed a decrease in the SP/AP wave form. In two patients with short administration, hearing loss was temporarily observed in middle and low frequencies; the hearing loss later improved more than before treatment in these patients. In only one patient, aggravation of hearing was observed after administration, but whether it was a side effect or not, remains to be understood. The period of observation of these results was a mean value of 4 months and 12 days. The Isosorbide therapy in patients with Menière's disease in expected to replace saccus surgery.
AuthorsT Yamazaki, T Imoto, N Hayashi, S Watanabe, H Kozaki, T Abe
JournalArchives of oto-rhino-laryngology (Arch Otorhinolaryngol) Vol. 234 Issue 1 Pg. 97-104 ( 1982) ISSN: 0302-9530 [Print] Germany
Vernacular TitleMenièrsche Krankheit und Isosorbid.
PMID7082223 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Sorbitol
  • Isosorbide
Topics
  • Adult
  • Edema (drug therapy)
  • Endolymph
  • Evoked Potentials, Auditory
  • Humans
  • Isosorbide (therapeutic use)
  • Male
  • Meniere Disease (drug therapy)
  • Sorbitol (analogs & derivatives)
  • Vertigo (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: